Milestone Pharmaceuticals Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Milestone Pharmaceuticals Inc. (MIST) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.83 million shares for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2020-10-23
- Milestone Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-03-31 was 3.29M shares, a 83.96% decline year-over-year.
- Milestone Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-03-31 was 20.51M shares, a 79.08% increase year-over-year.
- Milestone Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-03-31 was 11.45M shares.
- Milestone Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 2.58M shares, a 86.98% decline from fiscal 2018.
- Milestone Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 19.85M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2020-06-30 | 3.83M shares 10-Q · filed 2020-08-12 | |||
| 2020-03-31 | 3.29M shares 10-Q · filed 2020-05-14 | |||
| 2019-12-31 | 2.58M shares 10-K/A · filed 2020-10-23 | |||
| 2019-09-30 | 2.64M shares 10-Q · filed 2019-11-13 | |||
| 2019-06-30 | 2.44M shares 10-Q · filed 2020-08-12 | |||
| 2019-03-31 | 20.51M shares 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | 19.85M shares 10-K/A · filed 2020-10-23 | |||
| 2018-09-30 | 11.32M shares 10-Q · filed 2019-11-13 | |||
| 2018-06-30 | 11.24M shares 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | 11.45M shares 10-Q · filed 2019-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |